Johnson Chemical Pharmaceutical Works Co Ltd Total Liabilities
Johnson Chemical Pharmaceutical Works Co Ltd total liabilities. Based on the latest financial reports, Johnson Chemical Pharmaceutical Works Co Ltd (4747) has total liabilities worth NT$820.26 Million TWD (≈ $25.84 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Johnson Chemical Pharmaceutical Works Co to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Johnson Chemical Pharmaceutical Works Co Ltd (2009–2025)
Total liabilities of Johnson Chemical Pharmaceutical Works Co Ltd from 2009 to 2025. This chart illustrates how Johnson Chemical Pharmaceutical Works Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Johnson Chemical Pharmaceutical Works Co long-term investment intensity to see how much of total assets are deployed in long-term investments.
Johnson Chemical Pharmaceutical Works Co Ltd Competitors by Total Liabilities
The table below lists competitors of Johnson Chemical Pharmaceutical Works Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DreamCIS Inc
KQ:223250
|
Korea | ₩60.03 Billion |
|
Lixte Biotechnology Holdings Inc
NASDAQ:LIXT
|
USA | $1.69 Million |
|
Woorim Machinery Co. Ltd
KQ:101170
|
Korea | ₩17.19 Billion |
|
artnet AG Namens-Aktien o.N.
XETRA:ART
|
Germany | €29.69 Million |
|
Aminologics Co.Ltd
KQ:074430
|
Korea | ₩31.28 Billion |
|
Akoya Biosciences Inc
NASDAQ:AKYA
|
USA | $118.54 Million |
|
Atari S.A.
PA:ALATA
|
France | €102.00 Million |
|
High Tech Pharm Co. Ltd
KQ:106190
|
Korea | ₩12.57 Billion |
Liability Composition Analysis (2009–2025)
This chart breaks down Johnson Chemical Pharmaceutical Works Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Johnson Chemical Pharmaceutical Works Co.
Liquidity & Leverage Metrics
Johnson Chemical Pharmaceutical Works Co Ltd Total Liabilities Ratios Explained
Johnson Chemical Pharmaceutical Works Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Johnson Chemical Pharmaceutical Works Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Johnson Chemical Pharmaceutical Works Co Ltd (2009–2025)
The table below shows the annual total liabilities of Johnson Chemical Pharmaceutical Works Co Ltd from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$384.37 Million ≈ $12.11 Million |
+47.06% |
| 2024-12-31 | NT$261.36 Million ≈ $8.23 Million |
-18.58% |
| 2023-12-31 | NT$320.99 Million ≈ $10.11 Million |
+91.56% |
| 2022-12-31 | NT$167.56 Million ≈ $5.28 Million |
-6.34% |
| 2021-12-31 | NT$178.91 Million ≈ $5.64 Million |
-25.55% |
| 2020-12-31 | NT$240.33 Million ≈ $7.57 Million |
+131.54% |
| 2019-12-31 | NT$103.79 Million ≈ $3.27 Million |
+3.49% |
| 2018-12-31 | NT$100.29 Million ≈ $3.16 Million |
+4.87% |
| 2017-12-31 | NT$95.64 Million ≈ $3.01 Million |
-22.30% |
| 2016-12-31 | NT$123.09 Million ≈ $3.88 Million |
+28.26% |
| 2015-12-31 | NT$95.97 Million ≈ $3.02 Million |
-17.97% |
| 2014-12-31 | NT$117.00 Million ≈ $3.69 Million |
+16.92% |
| 2013-12-31 | NT$100.06 Million ≈ $3.15 Million |
+47.30% |
| 2012-12-31 | NT$67.93 Million ≈ $2.14 Million |
-23.07% |
| 2011-12-31 | NT$88.30 Million ≈ $2.78 Million |
+22.53% |
| 2010-12-31 | NT$72.06 Million ≈ $2.27 Million |
+25.94% |
| 2009-12-31 | NT$57.22 Million ≈ $1.80 Million |
-- |
About Johnson Chemical Pharmaceutical Works Co Ltd
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, card… Read more